+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Cell Therapy Market - Global Forecast 2025-2030- Product Image
Osteoarthritis Cell Therapy Market - Global Forecast 2025-2030- Product Image
Sale

Osteoarthritis Cell Therapy Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146545
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The osteoarthritis cell therapy market is undergoing structural transformation as advances in regenerative medicine redefine treatment pathways and create commercial growth opportunities for industry participants worldwide. Strategic collaborations, technological breakthroughs, and evolving regulatory frameworks are shaping a competitive environment that demands proactive adaptation and market-driven innovation.

Market Snapshot: Osteoarthritis Cell Therapy Market Size and Growth Prospects

Driven by the urgent need for disease-modifying interventions beyond symptomatic relief, the osteoarthritis cell therapy market is witnessing strong expansion. With millions of adults affected by cartilage degradation and chronic joint pain, industry momentum is fueled by increasing scientific, clinical, and commercial investment. The market size and a robust CAGR reflect accelerated adoption of cell-based approaches and highlight a dynamic sector at an inflection point.

Scope & Segmentation of the Osteoarthritis Cell Therapy Market

This comprehensive report delivers an in-depth analysis of segmentation dynamics, regional factors, and new technology paradigms shaping the market landscape.

  • Product Type: Includes allogeneic therapies for scalability and rapid availability, and autologous treatments leveraging patient-derived cells for immune synergy.
  • Cell Type: Focuses on chondrocytes and a broad range of mesenchymal stem cells from adipose tissue (via liposuction, microfat grafting), bone marrow (iliac crest, vertebral aspiration), synovium, and umbilical cord tissue.
  • Source: Examines the impact of tissue origin, including adipose, bone marrow, synovium, and umbilical cord, on product quality and procurement efficiency.
  • Indication: Assesses differentiated clinical approaches across ankle, hip, knee, and shoulder therapy, reflecting varying procedural and rehabilitation protocols.
  • Application: Investigates core endpoints of cartilage regeneration, functional improvement, inflammation reduction, and pain relief guiding therapeutic development and market access.
  • End User: Maps deployment across ambulatory surgical centers, hospitals and clinics, as well as specialty clinics influencing distribution strategies.
  • Route Of Administration: Analyzes adoption of intra-articular injection and surgical implantation pathways.
  • Technique: Considers 3D bioprinting, injection, and scaffold-based delivery and their implications for procedural complexity and user training needs.
  • Regional Coverage: Tracks developments and forecasts across North and South America, numerous EMEA markets (including the UK, Germany, France, and others), as well as Asia-Pacific territories (such as China, Japan, India, and more).
  • Company Coverage: Reviews innovation pipelines and business strategies of sector leaders, including Mesoblast Limited, Kolon Life Science, Regeneus Limited, Vericel Corporation, Takeda Pharmaceutical, Exopharm Limited, ISTO Technologies, and Orthofix Medical.

Key Takeaways for Senior Decision-Makers

  • Automation and closed-system manufacturing are improving cell processing consistency and scale, reducing variability and accelerating clinical deployment.
  • Allogeneic cell platforms offer operational efficiencies and broad access, while autologous approaches reduce immunogenicity, supporting differentiated patient strategies.
  • Strategic alliances between biotech companies, pharmaceutical leaders, and technology providers are advancing next-generation cellular scaffolds and combination therapies.
  • Integration of real-time digital health solutions and companion diagnostics is personalizing patient selection, monitoring, and engagement throughout the treatment journey.
  • Therapy adoption patterns vary significantly by region, influenced by reimbursement policies, health system structure, and government-led regenerative initiatives.

Tariff Impact: Navigating 2025 U.S. Policy Shifts

Upcoming 2025 U.S. tariff changes affect sourcing of critical components, manufacturing costs, and cross-border industry ties. Companies are reassessing procurement strategies, localizing production, and re-evaluating partnerships to buffer tariff-induced expenses along the cell therapy supply chain. Enhanced regulatory intelligence and agile supply chain architecture are becoming essential as organizations address evolving trade compliance and safeguard project momentum.

Research Methodology & Data Sources

This report utilizes a rigorous mixed-methods approach, integrating secondary research from competitive intelligence sources, proprietary patent databases, and clinical trial registries. Expert interviews with sector specialists and regulatory advisors validated assumptions, while quantitative data triangulation included cross-referencing financial statements, government statistics, and stakeholder input across core geographies.

Why This Report Matters: Value for Your Strategic Decision-Making

  • Enables business leaders to benchmark emerging therapy models and identify high-potential opportunities by segment and region.
  • Supports strategic planning by illuminating operational, regulatory, and technological shifts critical for successful market participation.
  • Provides actionable, data-driven insights to streamline investment decisions and guide collaboration priorities.

Conclusion

By leveraging forward-looking insights and robust market analysis, organizations can optimize their approach to osteoarthritis cell therapy innovation. Effective engagement with dynamic trends will position stakeholders for sustainable growth and enhanced patient outcomes in a transforming therapeutic landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in allogeneic mesenchymal stem cell therapies for targeted knee cartilage repair trial outcomes
5.2. Integration of three-dimensional bioprinting and scaffold technologies to enhance cell therapy efficacy in osteoarthritis patients
5.3. Emergence of point-of-care autologous cell processing systems reducing treatment timelines in clinical osteoarthritis protocols
5.4. Regulatory harmonization efforts among FDA EMA PMDA accelerating market authorization pathways for osteoarthritis cell therapies
5.5. Economic modeling and health technology assessment shaping payer reimbursement strategies for advanced cell therapies in osteoarthritis management
5.6. Strategic collaborations between biotech innovators and orthopedic device manufacturers to commercialize combination cell therapy solutions
5.7. Adoption of patient-reported outcome measures and real-world evidence data to validate long-term efficacy of osteoarthritis cell treatments
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Osteoarthritis Cell Therapy Market, by Product Type
8.1. Introduction
8.2. Allogeneic
8.3. Autologous
9. Osteoarthritis Cell Therapy Market, by Cell Type
9.1. Introduction
9.2. Chondrocytes
9.3. Mesenchymal Stem Cells
9.3.1. Adipose Tissue
9.3.1.1. Liposuction
9.3.1.2. Microfat Grafting
9.3.2. Bone Marrow
9.3.2.1. Iliac Crest Aspiration
9.3.2.2. Vertebral Aspiration
9.3.3. Synovium
9.3.4. Umbilical Cord Tissue
10. Osteoarthritis Cell Therapy Market, by Source
10.1. Introduction
10.2. Adipose Tissue
10.3. Bone Marrow
10.4. Synovium
10.5. Umbilical Cord Tissue
11. Osteoarthritis Cell Therapy Market, by Indication
11.1. Introduction
11.2. Ankle
11.3. Hip
11.4. Knee
11.5. Shoulder
12. Osteoarthritis Cell Therapy Market, by Application
12.1. Introduction
12.2. Cartilage Regeneration
12.3. Functional Improvement
12.4. Inflammation Reduction
12.5. Pain Relief
13. Osteoarthritis Cell Therapy Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Hospitals & Clinics
13.4. Specialty Clinics
14. Osteoarthritis Cell Therapy Market, by Route Of Administration
14.1. Introduction
14.2. Intra-Articular Injection
14.3. Surgical Implantation
15. Osteoarthritis Cell Therapy Market, by Technique
15.1. Introduction
15.2. 3D Bioprinting
15.3. Injection
15.4. Scaffold-Based Delivery
16. Americas Osteoarthritis Cell Therapy Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Osteoarthritis Cell Therapy Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Osteoarthritis Cell Therapy Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Mesoblast Limited
19.3.2. Kolon Life Science, Inc.
19.3.3. Regeneus Limited
19.3.4. Vericel Corporation
19.3.5. Takeda Pharmaceutical Company Limited
19.3.6. Exopharm Limited
19.3.7. ISTO Technologies, Inc.
19.3.8. Orthofix Medical Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. OSTEOARTHRITIS CELL THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. OSTEOARTHRITIS CELL THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. OSTEOARTHRITIS CELL THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. OSTEOARTHRITIS CELL THERAPY MARKET: RESEARCHAI
FIGURE 32. OSTEOARTHRITIS CELL THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 33. OSTEOARTHRITIS CELL THERAPY MARKET: RESEARCHCONTACTS
FIGURE 34. OSTEOARTHRITIS CELL THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OSTEOARTHRITIS CELL THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CHONDROCYTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CHONDROCYTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY LIPOSUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MICROFAT GRAFTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MICROFAT GRAFTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ILIAC CREST ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ILIAC CREST ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY VERTEBRAL ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY VERTEBRAL ASPIRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SYNOVIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SYNOVIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY UMBILICAL CORD TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY UMBILICAL CORD TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SYNOVIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SYNOVIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY UMBILICAL CORD TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY UMBILICAL CORD TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ANKLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ANKLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY HIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY HIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY KNEE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY KNEE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SHOULDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SHOULDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CARTILAGE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CARTILAGE REGENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY FUNCTIONAL IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY FUNCTIONAL IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INFLAMMATION REDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INFLAMMATION REDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PAIN RELIEF, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INTRA-ARTICULAR INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SURGICAL IMPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SURGICAL IMPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SCAFFOLD-BASED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SCAFFOLD-BASED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 146. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 147. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 148. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 149. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 150. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 151. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 152. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 153. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 154. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 155. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 164. CANADA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 168. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 169. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 174. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 175. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 280. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 281. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 286. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 287. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
TABLE 302. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
TABLE 303. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2018-2024 (USD MILLION)
TABLE 304. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY MESENCHYMAL STEM CELLS, 2025-2030 (USD MILLION)
TABLE 305. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY ADIPOSE TISSUE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2018-2024 (USD MILLION)
TABLE 308. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY BONE MARROW, 2025-2030 (USD MILLION)
TABLE 309. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 310. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 311. FRANCE OSTEOARTHRITIS CELL THERAPY MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Osteoarthritis Cell Therapy market report include:
  • Mesoblast Limited
  • Kolon Life Science, Inc.
  • Regeneus Limited
  • Vericel Corporation
  • Takeda Pharmaceutical Company Limited
  • Exopharm Limited
  • ISTO Technologies, Inc.
  • Orthofix Medical Inc.

Related Topics

Related Reports

Cell Therapy Technologies Market - Global Forecast 2025-2030 - Product Image

Cell Therapy Technologies Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cell Therapy Market Report 2025 - Product Image

Cell Therapy Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cell therapy platform Market - Global Forecast 2025-2030 - Product Image

Cell therapy platform Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Allogeneic Cell Therapy - Global Strategic Business Report - Product Image

Allogeneic Cell Therapy - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033 - Product Image

Cell Therapy Market Size, Share, Trends and Forecast by Cell Type, Therapy Type, Therapeutic Area, End User, and Region, 2025-2033

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.